Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
KRAS G12C-mutated Non-Small Cell Lung Cancer and advanced Colorectal Cancer.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.